CAS 1686108-82-6 Cotadutide

Send Inquiry
CAS 1686108-82-6 Cotadutide
Details
CAS: 1686108-82-6
Core structure: GLP-1 receptor / glucagon receptor (GLP-1R/GCGR) dual agonist peptide, with structurally optimized balanced agonistic activity on both receptors, synergistically regulates glucose and lipid metabolism, with multiple metabolic effects of hypoglycemia, weight loss and improvement of hepatic steatosis
We also provide specifications from crude to 99% purity, please contact us for details!

Related documents
COA/MS/HPLC Report
Peptide Dissolution and Storage Guide
Category
Metabolic Regulatory Peptide / Dual Receptor Agonist
Category
Pharmaceutical Peptides
Share to
Description

Shanghai Sonyt Biotechnology Co., Ltd. is one of the leading manufacturers and suppliers of cas 1686108-82-6 cotadutide in China, also supports custom service. Welcome to wholesale bulk high quality cas 1686108-82-6 cotadutide from our factory. Contact us for more details.

 

Product name CAS:1686108‑82‑6:Cotadutide
Description Cotadutide is a new‑generation dual receptor agonist metabolic peptide. It can simultaneously activate GLP‑1 receptors and glucagon receptors, exerting synergistic metabolic regulatory effects: activating GLP‑1 receptors to glucose‑dependently promote insulin secretion, lower blood glucose, delay gastric emptying, and inhibit food intake; activating glucagon receptors to promote hepatic gluconeogenesis, enhance lipolysis and energy expenditure, and improve liver fat accumulation. It balances the agonistic activity of both receptors, significantly reduces weight and improves non‑alcoholic fatty liver while effectively lowering blood glucose. It is a cutting‑edge tool peptide for the research of metabolic diseases such as type 2 diabetes, obesity and NAFLD.
Peptide purity (HPLC, %) 95%/98%/99%
Theoretical molecular weight (Da) ~4500 (subject to actual synthetic batch)
Structure type Site‑modified linear long peptide, dual receptor agonistic activity

 

Product Basic Information Table

 

Product Standard English Name Product Abbreviation / Alias Function Tags (comma-separated) Core Structure Molecular Formula Exact Mass (Da) Average MW (Da) Modification Type Length (aa)
Cotadutide Cotadutide; Dual agonist peptide GLP-1/glucagon dual agonism, Hypoglycemic weight loss, Fatty liver improvement, Metabolic disease, Dual receptor agonist, Peptide drug Glucagon-like peptide backbone with site modifications balancing dual receptor activity Large modified peptide, subject to actual batch MS - ~4500 (theoretical) Amino acid site substitution modification ~40

Physicochemical Solubility & Storage Parameters

 

Product Code Appearance Long-term Storage Short-term Storage Solution Stability Solid Powder Stability
PEP-COT001 white powder Store at -20℃, sealed, dry & protected from light, aliquoted; avoid repeated freeze-thaw cycles Stable for 2 weeks at 2-8℃ sealed & dry; ice pack shipping recommended Stable for 7 days at 4℃; slowly degraded by peptidases at room temperature**Moderate water solubility, soluble in dilute acetic acid or weakly acidic buffer, prone to aggregation in neutral solution**. Stability better than native glucagon-like peptide after modification Stable for 2 years at -20℃ under dry & dark conditions

 

Functional Description

 

Product Code Frontend Short Summary (for search list display) Detailed Biological Function Description Applicable Research Areas (comma-separated) Targets / Pathways
PEP-COT001 GLP-1R/GCGR dual receptor agonist peptide that synergistically regulates glucose and lipid metabolism, lowers blood glucose, reduces weight and improves fatty liver Cotadutide exerts synergistic metabolic effects by simultaneously activating two G protein-coupled receptors: activates GLP-1 receptors in islets and gastrointestinal tract, promotes insulin secretion in a glucose-dependent manner, inhibits glucagon release, delays gastric emptying, reduces food intake, and steadily lowers blood glucose; activates glucagon receptors in liver and adipose tissue, promotes lipolysis, increases energy expenditure, reduces hepatic triglyceride deposition, and improves hepatic steatosis and insulin resistance. The two receptor effects are synergistic, achieving significant weight loss and liver metabolic improvement while effectively controlling blood glucose, with better effect than single GLP-1 receptor agonists. Type 2 diabetes research, Obesity and weight loss, Non-alcoholic fatty liver, Glucose-lipid metabolism regulation, Dual receptor agonists, Metabolic peptide drugs GLP-1 Receptor (GLP-1R) + Glucagon Receptor (GCGR); cAMP/PKA signaling pathway; Glucose-lipid metabolism and energy expenditure regulatory pathway

Hot Tags: cas 1686108-82-6 cotadutide, China cas 1686108-82-6 cotadutide manufacturers, suppliers, factory, 1566590-77-9, 2381089-83-2, 910463-68-2, CAS 121062 08 6, Melanotan I acetate, Melanotan II

Send Inquiry